sclerosing peritonitis a rare but fatal complication of peritoneal inflammation硬化性腹膜炎腹膜炎症的罕见但致命的并发症.pdf

Hindawi Publishing Corporation Mediators of Inflammation Volume 2012, Article ID 709673, 4 pages doi:10.1155/2012/709673 Review Article Sclerosing Peritonitis: A Rare but Fatal Complication of Peritoneal Inflammation ¨ Monika Merkle and Markus Wornle Medizinische Poliklinik, Campus Innenstadt, Klinikum der LMU, Pettenkoferstrasse 8a, 80336 Munchen, Germany ¨ Correspondence should be addressed to Monika Merkle, monika.merkle@med.uni-muenchen.de Received 31 December 2011; Accepted 22 January 2012 Academic Editor: Wolfgang Neuhofer ¨ Copyright © 2012 M. Merkle and M. Wornle. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Sclerosing peritonitis is a rare form of peritoneal inflammation with an often fatal outcome. The major risk factor of sclerosing peritonitis is peritoneal dialysis treatment but it can also occur following renal or liver transplantation or be associated with certain drug treatment. This article gives an overview of reasons and treatment options for sclerosing peritonitis and shows a summery of current literature about sclerosing peritonitis. Sclerosing peritonitis (SP) is a rare form of peritoneal 5 years and the incidence of SP in patients on PD treatment inflammation which involves both the visceral and the for less than 2 years is very low [6, 7]. Nonphysiologic dialysis parietal surfaces of the abdominal cavity. SP is characterized solutions may induce